A clinical study on kaphaj yonivyapada (vaginal candidiasis) white discharge

A clinical study to evaluate the effect of arkadi ksheera varti in the management of kaphaja yoivyapada (vaginal candidiasis) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107513

Enrollment

Registered

2026-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Married Women Patients diagnosed with Kaphaja Yonivyapada by KOH test

Exclusion criteria

Exclusion criteria: Pregnant Women Diagnosed case of Diabetes Mellitus Intra Uterine Contraeptive Devices Sexually Transmitted Disease

Design outcomes

Primary

Measure	Time frame
Reduction in Yonigata Lakshanas (vaginal symptoms) including Yonigata Srava (vaginal discharge), Yoni Pichilata (stickiness), Yoni Sheeta (coldness), Yoni Kandu (itching), and Yonigata Alpavedana (mild pain) assessed using a Female Genital Grading Table (symptom scoring scale) along with confirmation by KOH Test to evaluate the presence or reduction of fungal elements before and after treatment.Timepoint: Clinical assessment and laboratory investigation will be conducted at baseline (Day 0) and on Day 7 after completion of treatment to evaluate improvement in symptoms and reduction in fungal infection using the KOH Test.	—

Measure

Time frame

Reduction in Yonigata Lakshanas (vaginal symptoms) including Yonigata Srava (vaginal discharge), Yoni Pichilata (stickiness), Yoni Sheeta (coldness), Yoni Kandu (itching), and Yonigata Alpavedana (mild pain) assessed using a Female Genital Grading Table (symptom scoring scale) along with confirmation by KOH Test to evaluate the presence or reduction of fungal elements before and after treatment.Timepoint: Clinical assessment and laboratory investigation will be conducted at baseline (Day 0) and on Day 7 after completion of treatment to evaluate improvement in symptoms and reduction in fungal infection using the KOH Test.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Leela Ramakrishnan

Sri Jayendra Saraswathi Ayurveda College And Hospital Banalore Chennai Highway Nazrathpet,Chennai

drleela@gmail.com9942360360

Outcome results